Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$830M |
| 2 |
DXC Technology
DXC
|
+$472M |
| 3 |
Wabtec
WAB
|
+$382M |
| 4 |
Johnson & Johnson
JNJ
|
+$364M |
| 5 |
Citigroup
C
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.09B |
| 2 |
Bank of America
BAC
|
+$729M |
| 3 |
Rio Tinto
RIO
|
+$656M |
| 4 |
CVS Health
CVS
|
+$450M |
| 5 |
MetLife
MET
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.98% |
| 2 | Healthcare | 16.12% |
| 3 | Financials | 10.96% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Vanguard Large-Cap ETF
VV
$51.9B
| $12.5M | ﹤0.01% |
62,435
+550
| +0.9% | +$107K |
|
927
dLocal
DLO
$4.26B
| $12.5M | ﹤0.01% |
+237,820
| New | +$9.15M |
|
|
TSP
928
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $12.5M | ﹤0.01% |
+175,160
| New | +$7.54M |
|
929
DoubleVerify
DV
$1.62B
| $12.4M | ﹤0.01% |
+293,808
| New | +$10.5M |
|
|
KZR
930
DELISTED
Kezar Life Sciences
KZR
| $12.4M | ﹤0.01% |
227,835
+25,140
| +12% | +$1.43M |
|
|
TPGS
931
DELISTED
TPG Pace Solutions Corp.
TPGS
| $12.3M | ﹤0.01% |
+1,230,000
| New | +$12.4M |
|
932
Unilever
UL
$131B
| $12.2M | ﹤0.01% |
185,854
+9,859
| +6% | +$656K |
|
933
iShares Russell 1000 Growth ETF
IWF
$122B
| $12.2M | ﹤0.01% |
179,376
-1,056
| -0.6% | -$68.1K |
|
934
Texas Capital Bancshares
TCBI
$4.31B
| $12.2M | ﹤0.01% |
191,585
+413
| +0.2% | +$27.8K |
|
|
TBIO
935
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $12.1M | ﹤0.01% |
+30,511
| New | +$10.8M |
|
|
BNY
936
Bank of New York Mellon
BNY
$108B
| $12M | ﹤0.01% |
234,520
-2,970
| -1% | -$149K |
|
937
Fidelity National Financial
FNF
$13.9B
| $11.9M | ﹤0.01% |
285,126
-1,630
| -0.6% | -$71.2K |
|
|
DAWN
938
DELISTED
Day One Biopharmaceuticals
DAWN
| $11.8M | ﹤0.01% |
+518,966
| New | +$10.8M |
|
939
BrightView Holdings
BV
$1.31B
| $11.8M | ﹤0.01% |
730,800
+2,600
| +0.4% | +$45.7K |
|
940
Motorola Solutions
MSI
$69.4B
| $11.8M | ﹤0.01% |
54,236
-1,551
| -3% | -$310K |
|
941
Vanguard Total International Bond ETF
BNDX
$82B
| $11.7M | ﹤0.01% |
204,854
+31,867
| +18% | +$1.82M |
|
942
Pliant Therapeutics
PLRX
$67.5M
| $11.5M | ﹤0.01% |
396,509
+46,500
| +13% | +$1.45M |
|
943
Olema Pharmaceuticals
OLMA
$1.02B
| $11.5M | ﹤0.01% |
412,205
+42,200
| +11% | +$1.2M |
|
944
Invesco
IVZ
$13.3B
| $11.5M | ﹤0.01% |
429,608
+30,773
| +8% | +$839K |
|
945
International General Insurance
IGIC
$1.23B
| $11.3M | ﹤0.01% |
1,211,455
+148,700
| +14% | +$1.26M |
|
946
Brookfield Renewable
BEP
$10B
| $11.2M | ﹤0.01% |
289,029
+2,736
| +1% | +$108K |
|
947
AES
AES
$10.6B
| $11.1M | ﹤0.01% |
425,047
+7,621
| +2% | +$201K |
|
948
WD-40
WDFC
$3.1B
| $11.1M | ﹤0.01% |
43,180
-2,823
| -6% | -$722K |
|
|
MGP
949
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $11M | ﹤0.01% |
299,607
-5,011
| -2% | -$178K |
|
950
Carrier Global
CARR
$57.2B
| $10.9M | ﹤0.01% |
224,756
-16,262
| -7% | -$727K |
|
Similar funds
Franklin Resources's Q2 2021 Portfolio in Review
As of Q2 2021, Franklin Resources held 2,118 positions worth $262B, up 6.5% from $246B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q2 2021 filing shows 136 new, 842 increased, 777 reduced and 106 closed positions. Its largest new stake was Frontier Communications: 11,357,382 shares worth $300M. The largest sale was JPMorgan Chase, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Franklin Resources's largest Q2 2021 buy was Frontier Communications: 11,357,382 shares worth $300M.
- Franklin Resources added most to AbbVie in Q2 2021, an estimated $830M increase.
- Franklin Resources's biggest Q2 2021 reduction was JPMorgan Chase, cutting an estimated $1.09B.
- Franklin Resources fully exited INPHI CORPORATION in Q2 2021, selling an estimated $133M.
- Franklin Resources's ten largest holdings make up 13% of its $262B portfolio in Q2 2021.
- Franklin Resources opened 136 new positions and closed 106 in Q2 2021.
- Franklin Resources's portfolio value rose 6.5% quarter-over-quarter to $262B.
Based on Franklin Resources's 13F filing for Q2 2021, filed 13 Aug 2021.